| __timestamp | Amneal Pharmaceuticals, Inc. | Catalyst Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 106735000 | 10117774 |
| Thursday, January 1, 2015 | 136870000 | 11801342 |
| Friday, January 1, 2016 | 204747000 | 11369941 |
| Sunday, January 1, 2017 | 191938000 | 11375237 |
| Monday, January 1, 2018 | 210451000 | 19919204 |
| Tuesday, January 1, 2019 | 202287000 | 18842752 |
| Wednesday, January 1, 2020 | 190585000 | 16496715 |
| Friday, January 1, 2021 | 209563000 | 16936000 |
| Saturday, January 1, 2022 | 200046000 | 19789000 |
| Sunday, January 1, 2023 | 167778000 | 93150000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, research and development (R&D) is the lifeblood of innovation. Over the past decade, Amneal Pharmaceuticals, Inc. and Catalyst Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Amneal consistently allocated a significant portion of its resources to R&D, peaking in 2018 with a 97% increase from 2014. However, a notable decline of 20% was observed in 2023, reflecting potential strategic shifts or market challenges.
Conversely, Catalyst Pharmaceuticals, Inc. exhibited a more conservative approach until 2023, when their R&D spending surged by over 800% compared to 2014. This dramatic increase suggests a renewed focus on innovation, possibly driven by emerging opportunities or competitive pressures. These trends highlight the dynamic nature of pharmaceutical R&D and the strategic decisions that shape the future of healthcare.
Research and Development Investment: Johnson & Johnson vs Catalyst Pharmaceuticals, Inc.
Bristol-Myers Squibb Company or Amneal Pharmaceuticals, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Gilead Sciences, Inc. and Catalyst Pharmaceuticals, Inc.
R&D Insights: How Bio-Techne Corporation and Catalyst Pharmaceuticals, Inc. Allocate Funds
Research and Development Investment: Pharming Group N.V. vs Catalyst Pharmaceuticals, Inc.
Analyzing R&D Budgets: Grifols, S.A. vs Amneal Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Corcept Therapeutics Incorporated and Catalyst Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. or Ultragenyx Pharmaceutical Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Amneal Pharmaceuticals, Inc. vs Geron Corporation
Analyzing R&D Budgets: Amneal Pharmaceuticals, Inc. vs Galapagos NV
Comparing Innovation Spending: CymaBay Therapeutics, Inc. and Catalyst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Catalyst Pharmaceuticals, Inc. and Evotec SE